Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12110272 Deuterated tryptamine derivatives and methods of use

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Oct, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 9 Oct, 2024
Edits made to:
Infobox (+42 properties)
‌

 US Patent 12110272 Deuterated tryptamine derivatives and methods of use

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
121102720
Patent Inventor Names
Alex Nivorozhkin0
Michael Palfreyman0
Date of Patent
October 8, 2024
0
Patent Application Number
183534920
Date Filed
July 17, 2023
0
Patent Citations
‌
US Patent 7642344 Methods and compositions for determining the sequence of nucleic acid molecules
0
‌
US Patent 7745665 Substituted phenethylamines
0
‌
US Patent 8980880 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
0
‌
US Patent 9139821 Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
0
‌
US Patent 9226925 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
0
‌
US Patent 9421266 Safety of pseudoephedrine drug products
0
‌
US Patent 9435816 Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use
0
‌
US Patent 9458082 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
0
‌
US Patent 9775379 Method and system for drug delivery
0
‌
US Patent 9839241 Methods, devices and systems for pulmonary delivery of active agents
0
‌
US Patent 9974743 Device and method for delivery of a medicament
0
‌
US Patent 10015979 Isotopically modified compounds and their use as food supplements
0
‌
US Patent 10183001 Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
0
‌
US Patent 10519175 Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
0
‌
US Patent 10668030 Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
0
‌
US Patent 10721963 Electrically heated aerosol delivery system
0
‌
US Patent 10722479 Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2
0
‌
US Patent 10729706 Psilocybin and/or psilocin in combination with cannabinoids and/or terpenes
0
‌
US Patent 10738268 Cannabis nanoemulsion methods
0
‌
US Patent 11242318 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 10933073 Compositions and methods comprising a psilocybin derivative
0
‌
US Patent 11000534 Deuterated derivatives of psilocybin and uses thereof
0
‌
US Patent 11312684 Pharmaceutically acceptable salts of psilocin and uses thereof
0
‌
US Patent 11324762 Deuterated derivatives of psilocybin and uses thereof
0
‌
US Patent 11471417 Deuterated N,N-dimethyltryptamine compounds
0
‌
US Patent 11680043 Pharmaceutically acceptable salts of psilocin and uses thereof
0
‌
US Patent 11746088 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 7052846 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
0
‌
US Patent 11834410 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 11958807 Deuterated tryptamine derivatives and methods of use
0
Patent Primary Examiner
‌
Kamal A Saeed
0
CPC Code
‌
C07D 209/16
0
‌
C07B 2200/05
0
‌
A61K 9/20
0

Find more entities like US Patent 12110272 Deuterated tryptamine derivatives and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.